MoneyWorks4Me

With no major difference for the quarter endedDecember 2024 , the total revenue stood at Rs. 368.93  millions.The Company has registered profit of Rs. 65.08  millions for the quarter ended December 2024, a growth of 20.45%  over Rs. 54.03 millions millions achieved in the corresponding quarter of last year.The company reported a good operating profit of 104.03 millions compared to 85.39 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 368.93 356.60 3.46 1106.45 1031.24 7.29 1419.66 1367.49 3.82
Other Income 15.82 13.46 17.53 48.41 34.79 39.15 46.67 51.23 -8.90
PBIDT 104.03 85.39 21.83 343.76 267.43 28.54 377.85 354.90 6.47
Interest 1.10 0.70 57.14 3.41 2.13 60.09 2.71 3.67 -26.16
PBDT 102.93 84.69 21.54 340.35 265.30 28.29 375.14 351.23 6.81
Depreciation 7.79 6.30 23.65 19.37 17.21 12.55 23.40 22.59 3.59
PBT 95.14 78.39 21.37 320.98 248.09 29.38 351.74 328.64 7.03
TAX 30.06 24.36 23.40 85.73 67.15 27.67 91.98 82.58 11.38
Deferred Tax 0.06 -0.64 -109.38 0.73 -3.53 -120.68 -5.21 -2.25 131.56
PAT 65.08 54.03 20.45 235.25 180.94 30.02 259.76 246.06 5.57
Equity 44.13 44.13 0.00 44.13 44.13 0.00 44.13 44.13 0.00
PBIDTM(%) 28.20 23.95 17.76 31.07 25.93 19.80 26.62 25.95 2.55
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..